Removing only the segment that holds a small lung cancer, instead of the whole lobe, keeps more breathing capacity, and two large trials now show survival at least as good as lobectomy for peripheral tumors of 2 centimeters or less. This guide covers which tumors suit a segmentectomy, the JCOG0802, CALGB 140503 and JCOG1211 results, how the keyhole or robotic operation is planned and done, the risks, recovery, a typical Istanbul stay and follow-up at home.
About This Department
Surgical Oncology
Remove the segment, keep the lobe. For small tumors at the edge of the lung.
In JCOG0802, five-year survival reached 94.3 percent after segmentectomy against 91.1 percent after lobectomy for tumors of 2 centimeters or less.
94.3%
Five-year survival after segmentectomy in JCOG0802
98.0%
Relapse-free at five years for ground-glass tumors in JCOG1211
5 days
Hospital stay in a published Istanbul lung resection package
Free
Review of your scans before you book
Free consultation
The review costs nothing and carries no obligation. Send your thin-slice CT, any PET-CT, breathing tests and biopsy report, and our surgical oncology team will tell you whether a segmentectomy fits your tumor, which approach suits it, and how long to plan for. A coordinator replies in your own language.
A CT scan has found a small nodule at the edge of the lung, a biopsy or the scan pattern points to an early lung cancer, and the surgeon has suggested removing only the segment of lung that holds it instead of the whole lobe. Lung segmentectomy removes one or more anatomical segments of a lobe, each with its own artery, vein and airway, along with the lymph nodes that drain it, so that more healthy lung is kept while the cancer is taken out with a safe margin. Below you will find how the lung is divided, which tumors suit a segmentectomy, what three large Japanese and American trials found against lobectomy, how the operation is done, the risks, the recovery, how long to stay in Istanbul, and the follow-up at home.
How the lung is divided
Lobes and segments
Each lobe is made of smaller segments, each supplied by its own branch of the airway, artery and vein, and that arrangement lets the surgeon remove a segment along its natural borders. Because the segment comes out with its own vessels, its airway and the lymph nodes at its root, a segmentectomy gives a cleaner cancer operation than a wedge while keeping most of the lobe working, which matters for people with limited breathing reserve and for anyone who may need another lung operation in the future, since a second lung cancer develops in a few percent of patients each year after a first one, and a lobe saved now leaves room for that later operation.
1
Right lung
Three lobes, upper, middle and lower, divided into ten segments.
2
Left lung
Two lobes, upper and lower, divided into eight to ten segments.
Three ways to remove lung tissue
1
Wedge resection
A non-anatomical piece of lung around the nodule.
2
Segmentectomy
One or more segments with their artery, vein, airway and nodes.
3
Lobectomy
The whole lobe, long the standard for lung cancer.
Side by side
On a narrow screen, swipe the table sideways to see every column.
Lung resections compared
Operation
What is removed
Typical use
Wedge
A small piece around the nodule
Diagnosis, metastases, frail patients
Segmentectomy
One or more anatomical segments
Small peripheral lung cancers
Lobectomy
A whole lobe
Larger or central lung cancers
Which tumors suit a segmentectomy
Size, position and appearance on CT decide. Segmentectomy is considered for
tumors 2 centimeters or smaller in the outer third of the lung,
ground-glass nodules, hazy spots that are often slow-growing early cancers, up to 3 centimeters,
patients whose breathing tests limit how much lung can be removed,
and people who have had lung surgery before.
What ground-glass means
On CT, a ground-glass nodule looks like a faint haze through which vessels can still be seen. Many are early adenocarcinomas that spread rarely, while solid nodules are more often invasive.
Signs it may be time
A peripheral non-small-cell lung cancer of 2 centimeters or less, or a ground-glass-dominant tumor up to 3 centimeters, with no spread to lymph nodes, and a segment that can be removed with a clear margin.
Talk to us first
Tumors close to the center of the lung, tumors larger than 2 centimeters that look solid, lymph node involvement found before or during surgery, or a margin that cannot be kept clear within the segment.
What the trials found
For decades, lobectomy was preferred, because a 1995 American trial of 247 patients found that limited resections, segments or wedges, tripled the local recurrence rate. Better scans and techniques led three new trials to test the question again.
In Japan, JCOG0802 randomized 1,106 patients with tumors of 2 centimeters or less to segmentectomy or lobectomy. Five-year survival was 94.3 percent after segmentectomy and 91.1 percent after lobectomy, a difference large enough to show segmentectomy was better. Relapse-free survival was the same at 88.0 and 87.9 percent, but local recurrence occurred in 10.5 percent against 5.4 percent, and lung function at one year was 3.5 percent better after segmentectomy. Part of the survival gap came from deaths unrelated to the cancer, since other diseases caused 63 percent of deaths after lobectomy and 47 percent after segmentectomy, and the investigators linked this to the extra lung kept, which leaves more reserve for pneumonia, heart disease and a later second cancer. In North America, CALGB 140503 randomized 697 patients with tumors of 2 centimeters or less and clear lymph nodes to sublobar resection or lobectomy. Five-year disease-free survival was 63.6 and 64.1 percent and overall survival 80.3 and 78.9 percent.
Scroll sideways on small screens to see every column.
Randomized trials of segmentectomy and lobectomy
Trial
Patients
Five-year survival
JCOG0802, Japan, 2022
1,106
94.3 percent after segmentectomy, 91.1 after lobectomy
CALGB 140503, North America, 2023
697
80.3 percent after sublobar resection, 78.9 after lobectomy
JCOG1211, Japan, 2023
357 operated
Relapse-free survival 98.0 percent for ground-glass tumors up to 3 centimeters
Why local recurrence still matters
Recurrence near the staple line was more frequent after segmentectomy in JCOG0802, so margins at least as wide as the tumor and careful CT follow-up are part of the operation.
Less lung removed, the same chance of cure, for the right tumor.
How the operation is done
Planning starts on the CT, days before the operating room. Before surgery we complete
a three-dimensional reconstruction of the segment's vessels and airway from the CT,
breathing tests to measure how much lung function you can spare,
a PET-CT or lymph node sampling when the scan raises a question,
and, for a tiny or faint nodule, a small marker placed nearby so it can be found during surgery.
1
Keyhole or robotic access
Three or four small cuts between the ribs, with one lung resting.
2
Dividing the segment's vessels and airway
Each is identified, sealed and cut.
3
Marking the border
A dye injected into the blood or the airway shows the segment's edge.
4
Removing the segment and nodes
The segment is divided along its border with staplers, and nodes are sampled.
5
Checking the margin
The pathologist examines the margin and nodes during surgery, and the operation converts to lobectomy if needed.
Risks and how they are managed
Air leak
The cut surface between segments can leak air for a few days, more often than after lobectomy, and seals on its own in most cases.
Conversion to lobectomy
If nodes are involved or the margin is too close, the surgeon removes the lobe in the same operation.
Chest infection and irregular heartbeat
Prevented with breathing exercises and early walking, and treated with medicines when they occur.
Swipe sideways on a phone for the full table.
Safety figures from the trials
Trial
Complications
Deaths within 90 days
JCOG0802
Grade 2 or higher in 27 percent after segmentectomy and 26 percent after lobectomy
None in either group
JCOG1211
Grade 3 or 4 in 2 percent
None reported
The recovery
Most patients walk on the first day and go home after three to five days once the drain is out. Breathing exercises with a small device continue at home, and stamina builds week by week with walking. Pain along the ribs fades over weeks. Desk work returns in two to three weeks and heavy lifting after six. Lung function after a segmentectomy is closer to normal than after a lobectomy, which many patients notice on stairs and hills.
How long to stay in Istanbul
Plan for ten to fourteen days.
The timeline below also scrolls sideways on small screens.
A typical stay in Istanbul
Days
What happens
1 to 3
Consultations, CT planning and breathing tests
4 to 8
Surgery and recovery on the ward until the drain is out
9 to 14
Hotel stay, wound check, pathology and chest X-ray before the flight
A published Istanbul package for keyhole lung resection with node removal shows five nights on the ward, surgery and airport transfers included and the hotel paid separately. Expect a few days of tests first. Final pathology arrives within a week, and the surgeon clears you for the flight once an X-ray shows the operated lung has re-expanded, around the end of the second week.
What decides the cost
Keyhole or robotic surgery, three-dimensional planning, nodule marking, nights in hospital and pathology set most of the figure.
A quote you can compare names the approach, the planning and the stay. That figure comes only after our surgical oncology team reviews your CT, PET-CT and breathing tests, and the review costs nothing.
Arranging the trip
Our review starts the moment your thin-slice CT, breathing tests and any biopsy or PET-CT report reach us on WhatsApp, and the same coordinator follows your case from that first message to the scans you have at home a year later. Interpreters join for any language outside English, Arabic, French, Russian, Serbian, Romanian and Spanish, which the team speaks. Your room has a companion bed for one relative. For the rest of the trip, the international office handles the hotel booking, the visa invitation letter ten days ahead and the airport transfers. Halal, vegetarian or diabetic meals, a prayer room and a female physician can be requested.
Once you are back home
CT scans every six months for two years and then yearly watch the staple line and the rest of the lungs, and the images can be sent through the coordinator for review.
See a doctor the same day for any of these.
Fever or chills
Breathlessness that gets worse instead of better
Chest pain or coughing up blood
Redness, swelling or fluid at the drain site
Lung segmentectomy FAQ
Is segmentectomy as good as lobectomy?
For peripheral tumors of 2 centimeters or less, two large trials found survival at least as good after segmentectomy.
Will I lose less lung function?
Yes, modestly. In JCOG0802, lung function at one year was 3.5 percent better after segmentectomy.
Is the cancer more likely to come back locally?
Local recurrence was higher in JCOG0802, which is why margins and follow-up CT matter.
Can it be done by keyhole surgery?
Yes, in most patients, by VATS or robotic surgery.
Do I need chemotherapy afterward?
Rarely for small node-negative tumors. The pathology result decides.
Can a family member stay with me?
Yes. A relative sleeps on the companion bed in your room, and a hotel nearby is booked for anyone else.
References
Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L), a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607-1617.
Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med. 2023;388(6):489-498.
Aokage K, Suzuki K, Saji H, et al. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211), a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. 2023;11(6):540-549.
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60(3):615-622.
Editor's note
Written by the Biruni Hospital medical editorial team. Reviewed by Assistant Professor Muhammet Sinan DAĞDEVİREN, Otorhinolaryngology.